Document Detail

Bleeding times and the antithrombotic effects of high-dose aspirin, hirudin and heparins in the rat.
MedLine Citation:
PMID:  9868857     Owner:  NLM     Status:  MEDLINE    
Bleeding can occur unexpectedly during antithrombotic therapy. Impaired haemostasis is commonly measured by the bleeding time. We measured it by 3 methods in controls and in anticoagulated animals and related it to their antithrombotic status. In 42 control rats template, tail-tip transection and needle occlusion bleeding times correlated poorly (r = 0.05-0.34). The template method had the best range (mean 126.97 +/- SEM secs) and consistency. In 10 control animals it correlated mildly (r = 0.55) with venous thrombus in the same animal. Thrombus was measured by its weight deposited on platinum wires (2 cm long, 0.4 mm diameter) set in vein and in artery for 1 h. In respective groups of 10 rats, a decrease of mean thrombogenesis was obtained using aspirin, heparin and low molecular weight heparin in 2 dosages and hirudin in 1 dosage. The drugs reduced mean venous thrombus by 13-86 per cent of the mean control thrombus, and prolonged the mean template bleeding time by 29-199 per cent. The ranking of the drugs according to their increase of template bleeding time was virtually the same as the ranking given by their reduction of thrombus weight (Spearman rank coefficient 0.81, sig 0.007). The transection test produced a similar ranking and similar correlation with thrombus (0.71, sig 0.049). Low molecular weight heparin induced the greatest thrombus reduction (39 per cent) for least prolongation of bleeding time (24 per cent). Arterial thrombus was more variable. The bleeding times and thrombus weight were measured in each animal of 2 groups given aspirin, the template method correlating mildly with venous thrombus reduction (r = 0.23, 0.58 respectively), the transection method with arterial (0.74, 0.45) and the occlusion test poorly with either (0.13, 0.22). Bleeding time lengthens with increasing antithrombotic effect of drugs, but not in direct proportion, nor similarly with each drug.
S M Lavelle; M MacIomhair
Related Documents :
18586067 - Purity control of some chinese crude herbal drugs marketed in italy.
11778867 - Current status of the anticoagulant hirudin: its biotechnological production and clinic...
10567597 - Co-prescription of h2 receptor blockers and proton pump inhibitors with warfarin in gen...
2340197 - Drug adsorption to charcoals and anionic binding resins.
8864997 - The potential of topoisomerase i inhibitors in the treatment of cns malignancies: repor...
15530767 - Literacy demands of product information intended to supplement television direct-to-con...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Irish journal of medical science     Volume:  167     ISSN:  0021-1265     ISO Abbreviation:  Ir J Med Sci     Publication Date:    1998 Oct-Dec
Date Detail:
Created Date:  1999-01-13     Completed Date:  1999-01-13     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7806864     Medline TA:  Ir J Med Sci     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  216-20     Citation Subset:  IM    
Department of Experimental Medicine, University College, Galway, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antithrombins / pharmacology*
Aspirin / pharmacology*
Fibrinolytic Agents / pharmacology*
Hemostasis / drug effects*
Heparin / pharmacology*
Rats, Sprague-Dawley
Time Factors
Reg. No./Substance:
0/Antithrombins; 0/Fibrinolytic Agents; 50-78-2/Aspirin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Papillary carcinoma in a thyroglossal duct remnant--a review of thyroglossal surgery in a regional c...
Next Document:  Long term results of polytetrafluoroethylene in above knee femoropopliteal bypass for critical ischa...